DNAJA2 is implicated in cystic fibrosis and neurodegenerative diseases, mainly through degradation of misfolded cystic fibrosis transmembrane conductance regulator (CFTR) and inhibition of tau aggregation; however, its link to cancer development and p53 remains obscure [46,47,48]. Here, CFTR is linked to cystic fibrosis.